Skip to main content
Intermediate Formal IVT

Informed Consent for Treatment

A documented process by which a patient or their legal representative voluntarily agrees to a proposed psychiatric treatment after receiving adequate information about its risks, benefits, and alternatives.

Full Definition

Informed Consent for Treatment is both a legal doctrine and a clinical document type requiring that clinicians disclose sufficient information—including the nature of the proposed treatment, expected benefits, material risks, available alternatives, and consequences of refusal—to enable a competent patient or surrogate to make a voluntary, autonomous decision. In psychiatric settings, the process is particularly complex because decision-making capacity may fluctuate with psychiatric symptom severity. Editors of consent forms must ensure that language is clear, jargon-free for patient-facing versions, and legally precise for institutional and regulatory copies. The term should always appear in full on first use in any document; 'consent' alone is insufficient in clinical records.

Usage

Usage note: Do not abbreviate to 'consent' in clinical or legal documents without prior full-form reference. 'Assent' (agreement without full legal capacity) is distinct from 'consent' and must not be used interchangeably.

In Context

  • "The psychiatrist documented that informed consent for treatment was obtained after a 20-minute discussion of the risks and benefits of clozapine therapy." — Progress note
  • "The patient lacked capacity to provide informed consent for treatment; the legal guardian signed the consent form on their behalf." — Capacity assessment note

Also known as

treatment consent form consent to treatment

Contrasted with

treatment refusal involuntary treatment order

Don't confuse with

assent capacity determination Psychiatric Advance Directive

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON